Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan
SEC Form 4 Filing
Mary Lynne Hedley, a director at Eli Lilly, acquired 10 shares of common stock through a deferral plan, while also holding 98 shares indirectly through a trust.
Summary
- Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the company's common stock.
- On July 15, 2024, Ms. Hedley acquired 10 shares of common stock at a price of $950.46 per share.
- These shares were acquired through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
- The shares will be settled in common stock following Ms. Hedley's separation from service.
- Ms. Hedley also indirectly owns 98 shares of common stock through a trust.
- She disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction, which is generally neutral to positive. The director's acquisition of shares can be seen as a sign of confidence in the company.
Positives
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Future Outlook
The acquired shares will be settled in common stock following the reporting person's separation from service.
Industry Context
This is a routine filing related to insider transactions, which is common for publicly traded companies. It reflects the compensation structure for directors at Eli Lilly.
Comparison to Industry Standards
- Director stock acquisitions are a common practice in publicly traded companies, often as part of compensation packages.
- Deferral plans are also a standard method for directors to receive compensation in the form of company stock.
- The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for transparency.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/15/2024 | Date of the stock acquisition by Mary Lynne Hedley. |
| 07/16/2024 | Date the SEC Form 4 was signed. |
Keywords
Eli Lilly, Director, Stock Acquisition, Deferral Plan, Common Stock, Beneficial Ownership, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.